Abiopharma

Barclays is an international financial services group engaged in retail and commercial banking, credit cards, investment banking, wealth management and investment management services. Co. operates in the following areas of financial services: U.K. Banking, Private Clients and International, Barclaycard, Barclays Capital and Barclays Global Investors. As of Dec 31 2004, Co. had total assets of $522,089,000,000 and total deposits of $328,742,000,000. In addition, Co. operated 2,902 branches worldwide.

Additional info from NASDAQ:
Barclays is a universal bank headquartered in the United Kingdom. It operates via two principal segments; U.K. (38% of profit before tax) and International (62% of PBT). In its U.K. segment, the bank provides current accounts, mortgages, savings and investment management services, credit cards, and business banking services to retail clients and small and medium-size enterprises. The international segment includes a corporate bank offering banking solutions to large corporates, a bulge-bracket global investment bank, and a credit card and payments business. In 2018, Barclays generated roughly 52% of its income from the U.K. and 34% from the United States.

Additional info from OTC:
Barclays is an international financial services group engaged in retail and commercial banking, credit cards, investment banking, wealth management and investment management services. Co. operates in the following areas of financial services: U.K. Banking, Private Clients and International, Barclaycard, Barclays Capital and Barclays Global Investors. As of Dec 31 2004, Co. had total assets of $522,089,000,000 and total deposits of $328,742,000,000. In addition, Co. operated 2,902 branches worldwide.